Top Industry News
- PMDA Notifications regarding safety measures (medicinal products)
- TGA New Medicine Adverse Event Search for Sponsors
- PMDA Request Regarding the Proper use of Uterotonic Drugs" has been posted in "Notifications from Pharmaceutical Companies Regarding Proper Use, etc."
- Levothyrox and Levothyroxine Medicines: Information Regarding the Availability of Euthyrox
- FDA Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions
- FDA Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act
- FDA Select Updates for the 506J Guidance: 506J Device List and Additional Notifications
- MDA POSSIBLE WAYS TO REGISTER IVD ANALYZER
- MHRA Guidance on International Recognition Procedure
- MHRA Guidance on Medicines Marketing Authorisation: Change of Ownership
- MHRA Guidance on Qualified Person Responsible for Pharmacovigilance (QPPV) Including Pharmacovigilance System Master Files (PSMF)
- Are you Familiar with Strategies for the Industry to Safeguard Cosmetic Ingredients when Facing Scrutiny in Great Britain?
- UK Industry Urged to Disclose PFAS Elimination Plans in Response to Environment Agency's Questionnaire on Cosmetic Ingredients
- MHRA Guidance to Help Applicants and Licence Holders Get and Maintain a Manufacturer Licence
- MHRA Authorises World-First Gene Therapy that Aims to Cure Sickle-Cell Disease and Transfusion-Dependent β-thalassemia
- The Minamata Convention Progresses Towards Eliminating the Utilization of Mercury in Cosmetic Products
- European Union's Latest Information on Hydroxypropyl P-Phenylenediamine and Its Dihydrochloride Salt (A165) (CAS/EC No. 73793-79-0/827-723-1 and 1928659-47-5/-)
- EU Provides an Update on Hydroxypropyl P-Phenylenediamine and its Dihydrochloride Salt (A165) (CAS/EC No. 73793-79-0/827-723-1 and 1928659-47-5/-). Preliminary Opinion - Comments Deadline: January 8, 2024
- Revisions to the Turkish Food Codex Regarding Infant and Follow-up Formulas (Communiqué No: 2019/14)
- FDA Update-Electronic Submission Process for Food Ingredient and Packaging Materials Submissions: November 2023
- EFSA Unveils TKPlate for Ensuring Food Safety without Resorting to Animal Testing
- FDA Suggests a Regulation Change to Revoke the Approval for the use of Brominated Vegetable Oil (BVO) in food
- MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
- Industry Calls for Revisions in FDA’s CGT Manufacturing Change Guidance
- PMDA List of Recovered Pharmaceuticals (Including In Vitro Diagnostic Drugs), Quasi-Drugs, and Cosmetics